Gut microbiota-derived metabolites: Potential targets for cardiorenal syndrome
Pharmacological Research,
Год журнала:
2025,
Номер
unknown, С. 107672 - 107672
Опубликована: Фев. 1, 2025
The
characteristic
of
cardiorenal
syndrome
(CRS)
is
simultaneous
damage
to
both
the
heart
and
kidneys.
CRS
has
caused
a
heavy
burden
mortality
incidence
rates
worldwide.
regulation
host
microbiota
metabolism
that
triggers
kidney
an
emerging
research
field
promotes
new
perspective
on
cardiovascular
risk.
We
summarize
current
studies
from
bench
bedside
gut
microbiota-derived
metabolites
better
understand
in
context
metabolites.
focused
involvement
pathophysiology
CRS,
including
lipid
cholesterol
disorders,
coagulation
abnormalities
platelet
aggregation,
oxidative
stress,
endothelial
dysfunction,
inflammation,
mitochondrial
energy
vascular
calcification
renal
fibrosis,
as
well
therapeutic
approaches
targeting
which
provides
innovative
treatment
approach
for
improve
patient
prognosis
overall
quality
life.
Язык: Английский
Natural products in traditional Chinese medicine for renal fibrosis: a comprehensive review
Frontiers in Pharmacology,
Год журнала:
2025,
Номер
16
Опубликована: Апрель 16, 2025
Renal
fibrosis
represents
the
terminal
pathological
manifestation
of
most
chronic
kidney
diseases,
driving
progressive
loss
renal
function.
Natural
products
have
emerged
as
promising
therapeutic
agents
for
preventing
and
ameliorating
due
to
their
multi-target
efficacy
favorable
safety
profiles.
In
this
review,
we
conducted
a
comprehensive
literature
search
on
PubMed
using
keywords
“natural
product”
“renal
fibrosis”
from
2004
2025,
identifying
704
relevant
articles.
We
systematically
categorize
discuss
biological
effects
key
natural
formulations
with
antifibrotic
potential,
focusing
five
major
classes:
glycosides,
flavonoids,
phenolic
compounds,
anthraquinones,
terpenoids.
Representative
compounds
each
category
are
highlighted
mechanisms
action,
including
modulation
oxidative
stress,
inflammation,
autophagy,
signaling
pathways.
This
review
aims
provide
theoretical
foundation
development
product-based
therapies
combat
fibrosis,
offering
insights
into
potential
future
research
directions.
Язык: Английский
Perturbed gut microbiota and serum metabolites are associated with progressive renal fibrosis
Frontiers in Medicine,
Год журнала:
2025,
Номер
12
Опубликована: Апрель 28, 2025
Introduction
The
intricate
pathogenesis
of
renal
fibrosis
necessitates
identifying
biomarkers
at
various
stages
to
facilitate
targeted
therapeutic
interventions,
which
would
enhance
patient
survival
rates
and
significantly
improve
prognosis.
Methods
We
investigated
the
changes
in
gut
microbiota
serum
metabolites
during
early,
middle,
late
rats
using
16S
rDNA
sequencing
UPLC-QTOF/MS-based
metabolomics.
Results
identified
5,
21,
14
potential
microbial
markers
19,
23,
31
metabolic
MOD1,
MOD2,
MOD4
groups,
respectively.
Bifidobacterium
was
as
a
shared
marker
between
MOD1
MOD2
groups;
Prevotellaceae_NK3B31_group
Bacteroides
were
groups.
pathways
arachidonic
acid
metabolism
retinol
found
play
significant
role
modulation
1,
2,
4
weeks.
Notably,
8,9-EET
5(S)-HPETE
within
these
emerged
critical
determinants
influencing
fibrosis.
Discussion
Our
findings
demonstrated
that
severity
is
associated
with
dysbiosis
alterations
metabolites.
Язык: Английский
Huangkui capsules regulate tryptophan metabolism to improve diabetic nephropathy through the Keap1/Nrf2/HO-1 pathway
Frontiers in Pharmacology,
Год журнала:
2025,
Номер
16
Опубликована: Апрель 30, 2025
Background
Diabetic
nephropathy
(DN)
is
a
serious
complication
of
diabetes
and
one
the
leading
causes
end-stage
renal
disease.
Huangkui
capsule
(HKC),
traditional
Chinese
patent
medicine,
widely
used
in
clinical
practice
for
treatment
chronic
glomerulonephritis.
However,
therapeutic
effects
underlying
mechanisms
HKC
DN
remain
poorly
understood.
Methods
was
induced
db/db
mice,
which
were
randomly
divided
into
DN,
HKC-L,
HKC-H
IRB
groups,
db/m
mice
served
as
Control
group.
Biochemical
indices
blood
urine
samples
from
measured,
HE
staining,
Masson
staining
PAS
to
verify
anti-DN
effect
HKC.
The
levels
ROS
expression
Nrf
2
pathway-related
proteins
mRNAs
detected.
Metabonomic
analysis
investigate
role
tryptophan
metabolism
regulation
by
HK-2
cells
establish
model
high-glucose
(HG)
injury
vitro
,
given
supplementary
verification.
Sarpogrelate
hydrochloride
(SH)
combined
with
HKC,
5-HT
2A
R
inhibitor,
pathway
an
model.
Results
Treatment
significantly
inhibited
increase
glucose
Urinary
albumin/creatinine
ratio
(UACR),
improved
kidney
signs
reduced
level
oxidative
stress
through
Keap1/
/HO-1
pathway.
revealed
that
involved
process
improves
can
regulate
improve
regulation.
also
injuries
HG
cell
.
SH
administration
inhibiting
could
inhibit
synthesis
HG.
Conclusion
Our
study
demonstrate
regulating
Keap1/Nrf
pathway,
provides
new
insight
use
DN.
Язык: Английский